-
-
-
-
-
-
-
Exelixis (EXEL) PT Raised to $54 at H.C. Wainwright
-
-
-
-
-
-
-
Oppenheimer Reiterates Perform Rating on Exelixis (EXEL)
-
-
-
-
-
-
-
Exelixis Announces Second Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Biotech sector Q1 earnings preview from RBC Capital Markets
-
-
-
-
-
-
-
Exelixis (EXEL) PT Raised to $36 at Piper Sandler
-
-
-
-
-
-
-
Exelixis to Release Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
-
-
-
-
-
-
-
Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
-
1,217,303 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

